HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma.
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma.
复制标题
DOI：
10.1038/modpathol.2011.47
复制
发表时间：
2011-07
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
The HER2 oncogene was recently reported to be amplified and overexpressed in esophageal adenocarcinoma. However, the relationship of HER2 amplification in esophageal adenocarcinoma with prognosis has not been well defined. The scoring systems for clinically evaluating HER2 in esophageal adenocarcinoma are not established. The aims of the study were to establish a HER2 scoring system and comprehensively investigate HER2 amplification and overexpression in esophageal adenocarcinoma and its precursor lesion. Using a tissue microarray, containing 116 cases of esophageal adenocarcinoma, 34 cases of BE, 18 cases of low grade dysplasia and 15 cases of high grade dysplasia, HER2 amplification and overexpression were analyzed by HercepTest and CISH methods. The amplification frequency in an independent series of 116 esophageal adenocarcinoma samples was also analyzed using Affymetrix SNP 6.0 microarrays. In our studies, we have found that HER2 amplification does not associate with poor prognosis in total 232 esophageal adenocarcinoma patients by CISH and high density microarrays. We further confirm the similar frequency of HER2 amplification by CISH (18.10%; 21/116) and SNP 6.0 microarrays (16.4%, 19/116) in esophageal adenocarcinoma. HER2 protein overexpression was observed in 12.1 % (14/116) of esophageal adenocarcinoma and 6.67% (1/15) of HGD. No HER2 amplification or overexpression was identified in BE or LGD. All HER2 protein overexpression cases showed HER2 gene amplification. Gene amplification was found to be more frequent by CISH than protein overexpression in esophageal adenocarcinoma (18.10% vs 12.9%). A modified two-step model for esophageal adenocarcinoma HER-2 testing is recommend for clinical esophageal adenocarcinoma HER-2 trial.
登录
查看更多内容
影响因子：
158.5
作者：
Joensuu, H;Kellokumpu-Lehtinen, P;Isola, J
通讯作者：
Isola, J
影响因子：
45.3
作者：
Cobleigh, MA;Vogel, CL;Slamon, DJ
通讯作者：
Slamon, DJ
影响因子：
3.3
作者：
Brien, TP;Odze, RD;Ross, JS
通讯作者：
Ross, JS
影响因子：
3.1
作者：
Gamliel, Z;Krasna, MJ
通讯作者：
Krasna, MJ
影响因子：
11.5
作者：
Rauser, Sandra;Weis, Roland;Walch, Axel
通讯作者：
Walch, Axel